Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Hematology | Devices
Disease Category: Hemodialysis
Location: United States, NY
Clinical Trial Details
Research Study Summary
End-stage Renal Disease Hemodialysis
The purpose of this study is to test a new liquid drug (during the dialysis procedure) containing iron that may help maintain your iron storage ability for people who are on chronic hemodialysis for end-stage renal disease.
Study drug and study procedures will be made available to you at no cost.
To qualify, you must:
- Be at least 18 years old undergoing chronic hemodialysis for end-stage renal disease three times a week
You will not qualify if you:
- Are pregnant or breast-feeding
- Have HIV
- Have active infections
- Have participated in a clinical drug or device trial within the last 30 days
To Learn more
Both Male and Female
Date Last Changed:
July 25, 2013
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.